摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dibenzobarallene | 103515-22-6

中文名称
——
中文别名
——
英文名称
dibenzobarallene
英文别名
cis-9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboxylic acid anhydride;9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboxylic anhydride;17-Oxapentacyclo[6.6.5.0(2,7).0(9,14).0(15,19)]-nonadeca-2,4,6,9,11,13-hexaene-16,18-dione;17-oxapentacyclo[6.6.5.02,7.09,14.015,19]nonadeca-2,4,6,9,11,13-hexaene-16,18-dione
dibenzobarallene化学式
CAS
103515-22-6
化学式
C18H12O3
mdl
MFCD00152427
分子量
276.291
InChiKey
PSKVQQJLLWSBFV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    258-259 °C
  • 沸点:
    492.7±45.0 °C(Predicted)
  • 密度:
    1.375±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    21
  • 可旋转键数:
    0
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8

反应信息

  • 作为反应物:
    描述:
    dibenzobarallene 在 sodium tetrahydroborate 作用下, 以 四氢呋喃 为溶剂, 反应 4.0h, 以91%的产率得到2,3-(9,10-dihydro-9,10-anthracenediyl)-γ-butylactone
    参考文献:
    名称:
    通过蒽Diels–Alder序列合成取代的3-呋喃-2(5 H)-ones
    摘要:
    蒽和顺丁烯二酸酐的Diels-Alder加合物衍生的内酯进行去质子化然后进行亲电淬灭,可得到高产率的α-取代内酯。特别值得注意的是与氯代三甲基硅烷的反应,仅得到C-甲硅烷基化的产物。烷基化产物的快速真空热解(FVP)以良好的总产率提供了3-取代的呋喃-2(5 H)-一。
    DOI:
    10.1016/j.tetlet.2006.04.097
  • 作为产物:
    参考文献:
    名称:
    Fluorescent Cyanoacrylate Monomers and Polymers for Fingermark Development
    摘要:
    Cyanoacrylate esters with fluorescent side groups were synthesized and tested as agents for latent fingerprint development. Reactive monomers with benzyl, anthracyl, naphthyl, fluorenyl, propagyl, and cyanomethyl side groups were synthesized using the formation of an ethyl cyanoacrylate, anthracene adduct, followed by hydrolysis of the ethyl ester to the acid and esterification with a desired alcohol, and finally release of the monomer by retro-Diels-Alder with maleic anhydride. Monomers were prepared in high yield and purity as determined by spectral analysis. Attempts to synthesize these monomers from poly(ethyl cyanoacrylate) by transesterification and depolymerization resulted in low yields and low purity. The synthesized fluorescent monomers were found to be effective for latent fingerprint development in solution forming clear fluorescent fingerprint images suitable for forensic fingerprint comparison. These monomers can complement the current use of the commonly used nonfluorescent ethyl cyanoacrylate monomers for fingerprint development.
    DOI:
    10.1021/ma400837h
点击查看最新优质反应信息

文献信息

  • Synthesis, Anti-inflammatory and Analgesic Evaluation of Certain New 3a,4,9,9a-Tetrahydro-4,9-benzenobenz[f]isoindole-1,3-diones
    作者:A. A. Abu-Hashem、M. A. Gouda
    DOI:10.1002/ardp.201100020
    日期:2011.8
    analgesic and anti‐inflammatory activities, we reported here the synthesis and in‐vivo analgesic and anti‐inflammatory evaluation of various series of 2‐substituted‐3a,4,9,9a‐tetrahydro‐4,9‐benzeno‐benz[f]isoindole‐1,3‐diones: [4‐Bromobutoxy] 6, 5‐bromopentoxy 7, [4‐(4‐phenylpiperazin‐1‐yl)butoxy] 9, [5‐(4‐phenylpiperazin‐1‐yl)pentoxy] 10, 2‐(2(4)‐(4‐phenylpiperazin‐1‐yl)‐2‐oxoethyl/4‐oxobutyl 17, 19, [
    为了建立具有改善的镇痛和抗炎活性的新候选物,我们在此报告了各种系列的 2-取代 - 3a、4、9、9a-四氢 - 4 的合成和体内镇痛和抗炎评估, 9 - benzeno - benz [f]isoindole - 1,3- diones: [4 - bromobutoxy] 6, 5 - bromopentoxy 7, [4- (4- phenylpiperazin - 1 - yl) butoxy] 9, [5- (4) -Phenylpiperazin-1-yl) pentoxy] 10, 2- (2 (4) - (4-phenylpiperazin-1-yl) -2-oxoethyl / 4-oxobutyl 17, 19, [2 (4) - (4-methylpiperazine) -1-基] -2-氧乙基/4-氧丁基20、22、[2(4)-吗啉代-2-氧乙基/4-氧丁基]23、25和2(4)-(哌啶-1-基)
  • Improving the Affinity and Selectivity of a Nonpeptide Series of Cholecystokinin-B/Gastrin Receptor Antagonists Based on the Dibenzobicyclo[2.2.2]octane Skeleton
    作者:S. Barret Kalindjian、Ildiko M. Buck、Julia R. Cushnir、David J. Dunstone、Martin L. Hudson、Caroline M. R. Low、Iain M. McDonald、Michael J. Pether、Katherine I. M. Steel、Matthew J. Tozer
    DOI:10.1021/jm00021a019
    日期:1995.10
    described a novel series of nonpeptidic cholecystokinin-B (CCKB)/gastrin receptor antagonists based on a dibenzobicyclo[2.2.2]octane skeleton. We wish now to report on compounds arising out of our earlier work which have substantially greater affinity as antagonists for the CCKB/gastrin receptor system and which maintain, or improve on, the already high selectivity with respect to CCKA receptors. Thus
    我们最近描述了基于二苯并双环[2.2.2]辛烷骨架的一系列新的非肽胆囊收缩素-B(CCKB)/胃泌素受体拮抗剂。现在,我们希望报告由我们早期工作产生的化合物,这些化合物作为CCKB /胃泌素受体系统的拮抗剂具有更大的亲和力,并且相对于CCKA受体,该化合物保持或改善了已经很高的选择性。因此,顺式-7-[[[((1S)-[[3,5-二羧基-苯基)氨基]羰基] -2-苯基乙基]氨基]羰基] -8-[[(1-金刚烷基甲基)氨基]-羰基] -2,3:5,6-二苯并双环[2.2.2]辛烷在CCKB /胃泌素受体的小鼠皮膜中表达的pKi为8.80。这些受体相对于CCKA受体的选择性约为1000倍。
  • Fluorous Dienophiles Are Powerful Diene Scavengers in Diels−Alder Reactions
    作者:Stefan Werner、Dennis P. Curran
    DOI:10.1021/ol035214a
    日期:2003.9.1
    [reaction: see text] Three fluorous dienophiles have been synthesized, and their value in scavenging an excess diene after Diels-Alder reactions is shown. The resulting fluorous derivatives are separated by solid-phase extraction on fluorous silica gel (FSPE). The fluorous [1,2,4]triazoline-3,5-dione 10 reacted with most dienes within seconds or minutes.
    [反应:见正文]合成了三种氟二烯亲核体,并显示了它们在Diels-Alder反应后清除过量二烯的价值。通过在氟硅胶(FSPE)上进行固相萃取来分离所得的氟衍生物。氟[1,2,4]三唑啉-3,5-二酮10在数秒或数分钟内与大多数二烯反应。
  • Dicarboximide-based clathrate design. Host synthesis, inclusion formation and x-ray crystal structures of a free host and of inclusion compounds with 2- and 3- methylcyclohexanone, 3-methylcyclopentanone, butyronitrile, propan-1-ol and (?)-fenchone guests
    作者:Edwin Weber、Christiane Reutel、Concepci�n Foces-Foces、Antonio L. Llamas-Saiz
    DOI:10.1002/poc.610080306
    日期:1995.3
    Crystalline host compounds consisting of a roof-shaped dicarboxinide framework and pendant diarylethanol analogous subunits were synthesized and shown to form inclusion complexes with small organic molecules such as alcohols, amines, ketones or polar and apolar organic solvents. Clathrate efficiency and selectivity depend on the particular host structure. The crystal and molecular structures of a free
    合成了由屋顶形的二羧甲骨架和侧基二芳基乙醇类似的亚基组成的结晶主体化合物,显示出与小的有机分子(如醇,胺,酮或极性和非极性有机溶剂)形成包合物。包合物的效率和选择性取决于特定的宿主结构。游离主体化合物(2a)和包含化合物[2a·3-甲基环己酮(1:1),1a·3-甲基环戊酮(1:1),1a·2-甲基环己酮(1:1),通过x射线衍射分析确定1b·丁腈(1∶1),1b·丙-1-醇(2∶1)和1b·(-)-甲烯酮(1∶1)]。在所有结构中,羟基均参与分子内氢键,并且主体和客体分子仅通过晶格力保持。残留在主体基质中的通道和空腔足够大,可以允许来宾分子的无序或高热位移参数。所有客人的本地包装系数平均为0·42。
  • Molecular docking, modeling, semiempirical calculations studies and in vitro evaluation of new synthesized pyrimidin-imide derivatives
    作者:Ahmed M. Abo-Bakr、Hesham M. Alsoghier、Aboubakr H. Abdelmonsef
    DOI:10.1016/j.molstruc.2021.131548
    日期:2022.2
    with different anhydrides. The synthesized compounds have been investigated and put under several studies suc as, in vitro and in silico techniques, Lipinski's rule of five (RO5), semiempirical (PM6) computational calculations in addition of some physicochemical parameters measurments to evaluate their biological effect against Penicillin-Binding Protein 3 (PBP3) from Escherichia coli. These studies revealed
    通过 4,6-二苯基嘧啶-2-胺1与不同酸酐的缩合反应合成了新的嘧啶-酰亚胺衍生物2-7。已对合成的化合物进行了研究并进行了多项研究,例如体外和计算机技术、Lipinski 的五法则 (RO5)、半经验 (PM6) 计算计算以及一些物理化学参数测量,以评估它们对青霉素的生物效应。来自大肠杆菌的结合蛋白 3 (PBP3) 。这些研究表明,新合成的嘧啶-酰亚胺具有最小的结合能和良好的亲和力,特别是对配体分子5这可能被认为是 PBP3 蛋白的一种有前途的抑制剂。所有新衍生物的结构均通过其元素和光谱分析 IR、1 H NMR、13 C NMR 和 MS得到明确证实。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

鬼臼脂毒酮 鬼臼毒素-4-O-葡萄糖苷 鬼臼毒素 鬼臼毒素 苦鬼臼毒素 脱氧鬼臼毒素 磷酸依托泊甙 盾叶鬼臼素 澳白木脂素2 澳白木脂素1 替尼泊苷 托尼依托泊苷 去氧鬼臼毒素 克立米星C 他氟泊苷 丙氨酸,N-(羧基甲基)-(9CI) alpha-盾叶鬼臼素 alpha-依托泊苷 [(5R,5aR,8aR,9R)-9-(4-羟基-3,5-二甲氧基-苯基)-8-氧代-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二氧戊环-5-基]丁酸酯 TOP-53二盐酸盐 NK-611盐酸盐 5,8,8a,9-四氢-9-羟基-5-(3,4,5-三甲氧基苯基)-(5R,5aR,8aR,9S)-呋喃并[3',4':6,7]萘并[2,3-d]-1,3-二氧杂环戊烯-6(5aH)-酮 4’-去甲鬼臼毒素 4’-去甲基表鬼臼毒素-Β-D-葡萄糖甙 4-{[(5S,5aS,8aR,9R)-9-(4-羟基-3,5-二甲氧苯基)-8-羰基-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基]氨基甲酰}苯基乙酸酯 4,6-O-苄叉-Β-D-葡萄糖甙鬼臼毒素 4'-去甲基表鬼臼毒素 4'-O-脱甲基-4-((4'-(1'-苯甲基哌啶基))氨基)-4-脱氧鬼臼毒 4 ’-去甲去氧鬼臼毒素 3-羟基-4H-吡喃-4-酮 3-氨基-N-[(5S,5aS,8aR,9R)-9-(4-羟基-3,5-二甲氧苯基)-8-羰基-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基]苯酰胺 2’-O-没食子酰基金丝桃甙 2(3H)-硫代酰苯,3-乙基二氢-3-(1-甲基乙基)-(9CI) 2'-氯依托泊苷 1-羟基-17-氧杂五环[6.6.5.0~2,7~.0~9,14~.0~15,19~]十九碳-2,4,6,9,11,13-六烯-16,18-二酮(non-preferredname) (8aR,9S)-9-[[(2R)-7,8-二羟基-2-(2-噻吩基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5S,5aS,8aR,9R)-5-[(4-氟苯基)氨基]-9-(4-羟基-3,5-二甲氧基-苯基)-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二氧戊环-8-酮 (5S,5aR,8aR,9R)-9-(4-羟基-3,5-二甲氧基-苯基)-5-(4-羟基苯基)硫烷基-5a,6,8a,9-四氢-5H-异苯并呋喃并[5,6-f][1,3]苯并二噁唑-8-酮 (5R,5aR,8aS,9S)-9-[(4-氨基苯基)氨基]-5-(4-羟基-3,5-二甲氧苯基)-5,8,8a,9-四氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-6(5aH)-酮盐酸(1:1) (5R,5aR,8aR,9R)-9-羟基-10-甲氧基-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-9-[[(6R,7R,8R)-7,8-二羟基-2-(4-甲氧基苯基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-F][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-9-[[(6R,7R,8R)-7,8-二羟基-2-(2-羟基苯基)-4,4a,6,7,8,8a-六氢吡喃并[5,6-d][1,3]二恶英-6-基]氧基]-5-(3,4,5-三甲氧基苯基)-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-F][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-8-羰基-9-(3,4,5-三甲氧苯基)-5,5a,6,8,8a,9-六氢呋喃并[3',4':6,7]萘并[2,3-d][1,3]二噁唑-5-基乙酸酯 (5R,5aR,8aR,9R)-5-(4-乙氧基-3,5-二甲氧基-苯基)-9-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R,5aR,8aR,9R)-5-(3,5-二甲氧基-4-丙氧基-苯基)-9-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基-5a,8,8a,9-四氢-5H-异苯并呋喃并[6,5-f][1,3]苯并二氧戊环-6-酮 (5R)-5,8,8ab,9-四氢-5b-(3,4,5-三甲氧基苯基)呋喃并[3',4':6,7]萘并[2,3-d]-1,3-二氧杂环戊烯-6(5abH),9-二酮 (5-氯吡啶-3-基)丙酸甲酯 (3aS,4S,9R,9aR)-4-[(4-氟苯基)氨基]-9-(4-羟基-3,5-二甲氧基苯基)-6,7-二甲氧基-3a,4,9,9a-四氢-3H-萘并[3,2-c]呋喃-1-酮 (3aR,4S,9R,9aR)-4,6,7-三羟基-9-(4-羟基-3,5-二甲氧苯基)-3a,4,9,9a-四氢萘并[2,3-c]呋喃-1(3H)-酮 (1R,3aS,4R,6aR)-4-(1,3-苯并二氧戊环-4-基)-1-(1,3-苯并二氧戊环-5-基)-3,3a,4,6a-四氢-1H-呋喃并[3,4-c]呋喃-6-酮